IANNIS TALIANIDIS (BSRC Alexander Fleming)
Dr. Talianidis' interests focus on the molecular mechanisms governing the transcriptional regulation of liver-specific genes. His research is broadly centered around the analysis of the function of hepatic regulators and the general transcription machinery.
NEKTARIOS TAVERNARAKIS (Institute of Molecular Biology and Biotechnology)
Dr. Tavernarakis' lab uses the soil-dwelling, nematode worm Caenorhabditis elegans, to investigate the molecular mechanisms of neuronal function and dysfunction, focusing in the research directions of Ageing & energy metabolism, sensory transduction & integration as well as Neurodegeneration & Necrotic cell death.
DIMITRIS KONTOYIANNIS (BSRC Alexander Fleming)
Dr. Kontoyiannis' lab seeks to identify the biological functions of RBPs as epigenetic determinants of specific cellular processes, their effects in signal-dependent re-organization of RNPs, the effect of their dysfunction in life-threatening pathologies and their efficacy as targets for disease monitoring & treatment.
PASCHALIS SIDERAS (Biomedical Research Foundation of the Academy of Athens)
Dr. Sideras' area of focus include: Inflammation and Immunological Diseases.
KATIA KARALIS (Biomedical Research Foundation of the Academy of Athens)
Dr. Karalis' research focuses on understanding the role of stressful stimuli in the development and pathophysiology of inflammatory diseases and is based on in vitro and in vivo studies using transgenic animal models. The ultimate goal is to identify biomarkers for application to human diseases and evelopment of new therapeutic approaches.
EFTHIMIOS SKOULAKIS (BSRC Alexander Fleming)
Dr. Skoulakis' research focuses on understanding the molecular mechanisms and signaling systems that mediate learning and memory and how these are altered by disease and aging. The Drosophila model is used to study processes essential for learning and memory and to model the action of genes implicated in human neuronal dysfunctions.
EVANGELOS ANDREAKOS (Biomedical Research Foundation of the Academy of Athens)
Dr. Andreakos' research is centered around the impact of innate immunity on the adaptive immune response with special emphasis on the modulation of dendritic cell function, the regulation of T cell polarization, and their role in chronic inflammatory disease.
MARIA FOUSTERI (BSRC Alexander Fleming)
Dr. Fousteris' research is centred on the molecular mechanisms that couple arrest of active transcription to chromatin alteration and repair in healthy versus disease situations. To delineate these events, we employ advanced proteomics and high-throughput genomic approaches in combination with biochemical and cellular techniques.
PANAYOTIS VERGINIS (Biomedical Research Foundation of the Academy of Athens)
Dr. Verginis' primary research interests are in the area of immune regulation with emphasis on the maintenance and re-establishment of immunological tolerance.
SPIROS EFTHIMIOPOULOS (National and Kapodistrian University of Athens, Dept. of Biology)
Dr. Efthimiopoulos' research focuses on the molecular and cell biology of the Alzheimer's Amyloid Precursor Protein and presenilin 1. He has established an Alzheimer's disease research laboratory at the University of Athens focusing on the identification of transmembrane and cytosolic proteins that interact with APP and regulate its processing.
Graduate Program Lecturers
PETROS SFIKAKIS (National and Kapodistrian University of Athens, Medical School)
Dr. Sfikakis has contributed towards the understanding of the pathogenesis of autoimmune rheumatic diseases and improving the therapeutic approach of Systemic Lupus Erythematosus, systemic scleroderma, and Behçet's disease.
ATHANASIOS TZIOUFAS (National and Kapodistrian University of Athens, Medical School)
Dr. Tzioufas' Academic Fields of interest include: Internal Medicine, Rheumatology and Immunology.
GEORGE PANAYOTOU (BSRC Alexander Fleming)
Dr. Panaytou's research focuses on the complex signaling pathways that are activated in mammalian cells upon their stimulation by extracellular stimuli. These processes are very important for the development of many human diseases, and our group investigates these pathways particularly in terms of their role in cancer development.
DESPINA SANOUDOU (National and Kapodistrian University of Athens, Medical School)
Dr. Sanoudou's research team focuses on the discovery of novel diagnostic and prognostic markers, the identification of novel therapeutic targets, and the evaluation of chemical compounds against cardiovascular diseases.
PANTELIS HATZIS (BSRC Alexander Fleming)
Dr. Hatzis' interests focus on investigating Wnt-dependent transcriptional regulation in the intestine and liver and its contribution to normal homeostasis and carcinogenesis, through use of high-throughput techniques, such as ChIP- and RNA-seq and proteomic approaches.
VASSO KOSTOUROU (BSRC Alexander Fleming)
Dr. Kostourou's research focuses on understanding how vascular adhesion controls blood vessel formation and function during development and in cancer, through use of genetically modified mouse models, various ex vivo and in vitro cellular and molecular assays, advanced 4D-live imaging and large-scale proteomics and genomics approaches.
ELINA PAPANIKOLAOU (National and Kapodistrian University of Athens, Medical School)
Dr. Papanikolaou's research interests focus on the: Molecular biology of viruses and/or bacteria, Development of gene therapy approaches and Molecular genetics of inherited diseases.
CHRISTOFOROS NIKOLAOU (University of Crete, Department of Biology)
Dr. Nikolaou's research interests are related to functional aspects of DNA structure and epigenomic regulation, the evolution of the information content of biological sequences and large-scale properties of genome organization and architecture.
GEORGE KOLLIAS (National and Kapodistrian University of Athens, Medical School)
Dr. Kollias has pioneered genetic approaches to study the function of TNF in animal models of human diseases and has a long standing expertise in transgenic, gene mutational and knockout technologies, molecular and cell biology and immunology.
DIMITRIOS BOUMPAS (National and Kapodistrian University of Athens, Medical School)
Dr. Boumpas' primary clinical and research interests are in the areas of human autoimmunity with emphasis on systemic lupus erythematosus (SLE) and inflammatory arthritis. His work on the treatment of lupus nephritis has shaped immunosuppressive therapy for autoimmune rheumatic diseases internationally.
MICHALIS KOUTSILIERIS (National and Kapodistrian University of Athens, Medical School)
Dr. Koutsilieris' scientific interests are centered in the areas of Medical Physiology, Molecular Endocrinology, Molecular Oncology, Hormones & Cancer, Bones.
MARIA DENIS (Biomedcode Hellas SA)
Dr. Denis is CEO of Biomedcode Hellas SA since 2010, a Contract Research Organization providing full preclinical drug evaluation services using a unique collection of mouse models of human inflammatory diseases mimicking Rheumatoid Arthritis, Intestinal Inflammation, Multiple Sclerosis and others.
LEONIDAS ALEXOPOULOS (ProtAtOnce)
Dr. Alexopoulos is Founder and Chief Scientific Advisor of Protat once. He has strong experience in multiplex proteomic assays for drug discovery in both experimental and computational aspects and has collaborated and worked with leading companies in the area of Systems Pharmacology like Pfizer, Vertex and Boehringer Ingelheim.
ALEX STRONGILOS (proACTINA SA)
Dr. Strongilos is President & CEO of proACTINA SA a research driven SME company based in Athens-Greece. Its primary goal is to develop innovative products and technologies within the Life Sciences sector and subsequent exploitation of the intellectual property generated.